Adam Feuerstein Follow

Every article

1. Wednesday, October 7, 2026

2. 08:30health
   STAT+: Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down STAT (paywall) by Adam Feuerstein

3. Thursday, October 1, 2026

4. 16:31health
   Mistrust in science and a juicy gene-editing lawsuit STAT (paywall) by Adam Feuerstein, Elaine Chen
5. 10:30health
   STAT+: Why a Huntington’s patient isn’t fazed by the waning effect of UniQure’s gene therapy STAT (paywall) by Adam Feuerstein
6. 10:30health
   STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await STAT (paywall) by Adam Feuerstein

7. Tuesday, September 29, 2026

8. 11:05health
   STAT+: UniQure’s gene therapy continues to slow Huntington’s progression after four years STAT (paywall) by Adam Feuerstein

9. Thursday, September 24, 2026

10. 19:30health
    The FDA’s Overton era, and dispatches from Shanghai STAT (paywall) by Elaine Chen, Adam Feuerstein
11. 10:30health
    STAT+: Why Gilead can’t stop talking about its ambitions in immunology STAT (paywall) by Adam Feuerstein

12. Friday, September 18, 2026

13. 13:42health
    STAT+: Roche expands its Boston footprint with new research center STAT (paywall) by Meghana Keshavan, Adam Feuerstein story

14. Thursday, September 17, 2026

15. 16:26health
    Definium’s new psychedelics data, and a reprieve for international scientists STAT (paywall) by Elaine Chen, Adam Feuerstein
16. 10:30health
    STAT+: A Sellas immunotherapy study, long delayed, will end in failure STAT (paywall) by Adam Feuerstein story
17. 10:30health
    STAT+: A biotech hedge fund births a new immunology company STAT (paywall) by Adam Feuerstein

18. Tuesday, September 15, 2026

19. 10:30health
    STAT+: Vera kidney drug Trutakna shows strong final results in Phase 3 trial STAT (paywall) by Adam Feuerstein

20. Friday, September 11, 2026

21. 08:30health
    STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field STAT (paywall) by Allison DeAngelis, Adam Feuerstein story

22. Thursday, September 10, 2026

23. 17:29health
    Why two promising heart drugs flopped and what’s next STAT (paywall) by Adam Feuerstein, Elaine Chen story
24. 10:30health
    STAT+: Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon STAT (paywall) by Adam Feuerstein story
25. 10:30health
    STAT+: What to expect from UniQure’s upcoming Huntington’s gene therapy readout STAT (paywall) by Adam Feuerstein

26. Tuesday, September 8, 2026

27. 10:00health
    STAT+: Roivant lung disease drug hits mid-stage study goals STAT (paywall) by Adam Feuerstein